Suchergebnisse - "Gyawali, Bishal"

PubPharm (308)

51

Aumolertinib in EGFR-Mutant Lung Cancer : Will the Promise of Cost Disruption Ease Access?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Aggarwal, C. | Gyawali, B.

CommentOn: J Clin Oncol. 2022 Sep 20;40(27):3162-3171. - PMID 35580297

52

Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries

enthalten in: JAMA network open | 2022

von Rubagumya, F. | Hopman, W. | Gyawali, B. | +10

ErratumIn: JAMA Netw Open. 2022 Sep 1;5(9):e2235554. - PMID 36125816

53

Cancer Medicines : What Is Essential and Affordable in India?

enthalten in: JCO global oncology | 2022

von Sengar, M. | Fundytus, A. | Hopman, W. | +14

54

Health System Preparedness in Tackling the COVID-19 in Nepal: a Qualitative Study Among Frontline Healthcare Workers and Policymakers

enthalten in: ResearchSquare.com | 2022

von Shrestha, N. | Mishra, S. | Ghimire, S. | +7

55

Lessons learned from the accelerated approval of cancer drugs

enthalten in: Clinical advances in hematology & oncology : H&O | 2022

von Gyawali, B.

56

Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies

enthalten in: Journal of diabetes & metabolic disorders | 2022

von Gaba, U. | Altamish, M. | Azharuddin, M. | +5

57

Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies

enthalten in: Journal of diabetes & metabolic disorders | 2022

von Gaba, U. | Altamish, M. | Azharuddin, M. | +5

58

Risk and benefit for umbrella trials in oncology : a systematic review and meta-analysis

enthalten in: BMC medicine | 2022

von Strzebonska, K. | Blukacz, M. | Wasylewski, M. | +3

59

Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis

enthalten in: BMC medicine | 2022

von Strzebonska, K. | Blukacz, M. | Wasylewski, M. | +3

60

Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis

enthalten in: BMC medicine | 2022

von Strzebonska, K. | Blukacz, M. | Wasylewski, M. | +3